These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 10601079)

  • 21. Decreases in ovarian cytochrome P450c17 alpha activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome.
    Nestler JE; Jakubowicz DJ
    N Engl J Med; 1996 Aug; 335(9):617-23. PubMed ID: 8687515
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metformin versus ethinyl estradiol-cyproterone acetate in the treatment of nonobese women with polycystic ovary syndrome: a randomized study.
    Morin-Papunen L; Vauhkonen I; Koivunen R; Ruokonen A; Martikainen H; Tapanainen JS
    J Clin Endocrinol Metab; 2003 Jan; 88(1):148-56. PubMed ID: 12519844
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical study on treating insulin resistance and promoting ovulation in polycystic ovary syndrome].
    Liu ZA; Xue YM; Chen LX; Cai Q; Chen H; Zhang J; Cui QH; Ge J; Yuan T
    Zhonghua Fu Chan Ke Za Zhi; 2004 Sep; 39(9):586-90. PubMed ID: 15498183
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Two weeks of metformin improves clomiphene citrate-induced ovulation and metabolic profiles in women with polycystic ovary syndrome.
    Khorram O; Helliwell JP; Katz S; Bonpane CM; Jaramillo L
    Fertil Steril; 2006 May; 85(5):1448-51. PubMed ID: 16579997
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute effects of metformin therapy include improvement of insulin resistance and ovarian morphology.
    Bayrak A; Terbell H; Urwitz-Lane R; Mor E; Stanczyk FZ; Paulson RJ
    Fertil Steril; 2007 Apr; 87(4):870-5. PubMed ID: 17224152
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome.
    Piltonen T; Morin-Papunen L; Koivunen R; Perheentupa A; Ruokonen A; Tapanainen JS
    Hum Reprod; 2005 Jul; 20(7):1820-6. PubMed ID: 15802325
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Estradiol-to-testosterone ratio is associated with response to metformin treatment in women with clomiphene citrate-resistant polycystic ovary syndrome (PCOS).
    Horng SG; Wang TH; Wang HS
    Chang Gung Med J; 2008; 31(5):477-83. PubMed ID: 19097595
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endocrine and metabolic effects of metformin versus ethinyl estradiol-cyproterone acetate in obese women with polycystic ovary syndrome: a randomized study.
    Morin-Papunen LC; Vauhkonen I; Koivunen RM; Ruokonen A; Martikainen HK; Tapanainen JS
    J Clin Endocrinol Metab; 2000 Sep; 85(9):3161-8. PubMed ID: 10999803
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metformin effects on clomifene-induced ovulation in the polycystic ovary syndrome.
    Ben Ayed B; Dammak dit Mlik S; Ben Arab H; Trabelssi H; Chahtour H; Mathlouthi N; Dhuib M; Kassis M; Saiidane D; Trabelssi K; Guermazi M
    Tunis Med; 2009 Jan; 87(1):43-9. PubMed ID: 19522426
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metformin therapy in obese adolescents with polycystic ovary syndrome and impaired glucose tolerance: amelioration of exaggerated adrenal response to adrenocorticotropin with reduction of insulinemia/insulin resistance.
    Arslanian SA; Lewy V; Danadian K; Saad R
    J Clin Endocrinol Metab; 2002 Apr; 87(4):1555-9. PubMed ID: 11932281
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Co-administration of metformin during rFSH treatment in patients with clomiphene citrate-resistant polycystic ovarian syndrome: a prospective randomized trial.
    Yarali H; Yildiz BO; Demirol A; Zeyneloğlu HB; Yiğit N; Bükülmez O; Koray Z
    Hum Reprod; 2002 Feb; 17(2):289-94. PubMed ID: 11821265
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metformin therapy in women with polycystic ovary syndrome.
    Aruna J; Mittal S; Kumar S; Misra R; Dadhwal V; Vimala N
    Int J Gynaecol Obstet; 2004 Dec; 87(3):237-41. PubMed ID: 15548396
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of metformin on serum insulin and anti-Mullerian hormone levels and on hyperandrogenism in patients with polycystic ovary syndrome.
    Nascimento AD; Silva Lara LA; Japur de Sá Rosa-e-Silva AC; Ferriani RA; Reis RM
    Gynecol Endocrinol; 2013 Mar; 29(3):246-9. PubMed ID: 23194004
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolic and ovarian effects of rosiglitazone treatment for 12 weeks in insulin-resistant women with polycystic ovary syndrome.
    Cataldo NA; Abbasi F; McLaughlin TL; Basina M; Fechner PY; Giudice LC; Reaven GM
    Hum Reprod; 2006 Jan; 21(1):109-20. PubMed ID: 16155076
    [TBL] [Abstract][Full Text] [Related]  

  • 35. N-acetyl cysteine vs. metformin in treatment of clomiphene citrate-resistant polycystic ovary syndrome: a prospective randomized controlled study.
    Elnashar A; Fahmy M; Mansour A; Ibrahim K
    Fertil Steril; 2007 Aug; 88(2):406-9. PubMed ID: 17335818
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Randomized controlled trial of different doses of metformin for ovulation induction in infertile women with polycystic ovary syndrome.
    Weerakiet S; Sophonsritsuk A; Lertvikool S; Satirapot C; Leelaphiwat S; Jultanmas R
    J Obstet Gynaecol Res; 2011 Sep; 37(9):1229-37. PubMed ID: 21518135
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Specific factors predict the response to pulsatile gonadotropin-releasing hormone therapy in polycystic ovarian syndrome.
    Gill S; Taylor AE; Martin KA; Welt CK; Adams JM; Hall JE
    J Clin Endocrinol Metab; 2001 Jun; 86(6):2428-36. PubMed ID: 11397835
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of metformin and rosiglitazone, alone and in combination, on the ovary and endometrium in polycystic ovary syndrome.
    Legro RS; Zaino RJ; Demers LM; Kunselman AR; Gnatuk CL; Williams NI; Dodson WC
    Am J Obstet Gynecol; 2007 Apr; 196(4):402.e1-10; discussion 402.e10-1. PubMed ID: 17403436
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metformin regulates ovarian angiogenesis and follicular development in a female polycystic ovary syndrome rat model.
    Di Pietro M; Parborell F; Irusta G; Pascuali N; Bas D; Bianchi MS; Tesone M; Abramovich D
    Endocrinology; 2015 Apr; 156(4):1453-63. PubMed ID: 25590243
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Follistatin and activin A serum concentrations in obese and non-obese patients with polycystic ovary syndrome.
    Eldar-Geva T; Spitz IM; Groome NP; Margalioth EJ; Homburg R
    Hum Reprod; 2001 Dec; 16(12):2552-6. PubMed ID: 11726573
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.